Glibenclamide impairment of B-cell function involves alterations of cytoplasmic Ca2+ regulation
(1998) 34th Annual Meeting of the European Association for the Study of Diabetes (EASD) — Location: (Spain) Barcelona (8.September.1998)
Files
1998_Anello_EASD_Abstract_548.pdf
Abstract
Open Access - Adobe PDF
- 3.48 MB
Details
- Authors
- Abstract
- Chronic treatment with glibenclamide alters the cell response to various insulin secretagogues. The possible mechanisms have been studied with islets cultured for ISh in the presence of 10 mmo1/! glucose, with (test) or without (control) a therapeutical concentration of glibenclamide (10 nmol/l) […]
- Affiliations
Citations
Anello, M., Gilon, P., & Henquin, J.-C. (1998). Glibenclamide impairment of B-cell function involves alterations of cytoplasmic Ca2+ regulation. Diabetologia : clinical and experimental diabetes and metabolism, 41(Suppl 1), A141. https://hdl.handle.net/2078.5/118923 (Original work published 1998)